Evaluation of metronidazole and MK-910 in invasive amebiasis.
D000284:Administration, Oral; D001835:Body Weight; D004404:Dysentery, Amebic / Q000188:drug therapy* / Q000473:pathology; D004748:Entamoeba histolytica / Q000302:isolation & purification; D005243:Feces / Q000382:microbiology; D005461:Fluorine / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D008101:Liver Abscess, Amebic / Q000188:drug therapy / Q000473:pathology; D008297:Male; D008795:Metronidazole / Q000008:administration & dosage / Q000627:therapeutic use*; D009574:Nitro Compounds / Q000008:administration & dosage / Q000627:therapeutic use; D009593:Nitroimidazoles; D013997:Time Factors
D007093:Imidazoles; D009574:Nitro Compounds; D009593:Nitroimidazoles; D008795:Metronidazole; D005461:Fluorine; C002176:MK 190